These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 9566461)
1. Pharmacoeconomics and managed care: methodologic and policy issues. Luce BR Med Decis Making; 1998; 18(2 Suppl):S4-11. PubMed ID: 9566461 [No Abstract] [Full Text] [Related]
2. Forecasting the issues for managed care pharmacy. Navarro RP Am J Health Syst Pharm; 1998 Jan; 55(1):27-9. PubMed ID: 9437471 [No Abstract] [Full Text] [Related]
3. Pharmacoeconomics: a managed care perspective. Clouse JC Top Hosp Pharm Manage; 1994 Jan; 13(4):54-9. PubMed ID: 10130684 [TBL] [Abstract][Full Text] [Related]
5. Health plans join up for the genomics revolution. Carroll J Manag Care; 2009 Feb; 18(2):21-2, 24-5. PubMed ID: 19264022 [No Abstract] [Full Text] [Related]
6. Pharmacoeconomics: determining the value of drug therapy. Peterson C Healthplan; 1998; 39(3):44-50. PubMed ID: 10181751 [No Abstract] [Full Text] [Related]
7. Medical technology meets managed competition. Durenberger D; Foote SB J Am Health Policy; 1993; 3(3):23-8. PubMed ID: 10125731 [TBL] [Abstract][Full Text] [Related]
8. Pharmacoeconomics in managed care pharmacy. Penna P Manag Care Interface; 2001 Aug; 14(8):53-4. PubMed ID: 11517838 [No Abstract] [Full Text] [Related]
9. Pharmaceuticals in the era of cost-containment. Bischof RO Hosp Pract (1995); 1996 Dec; 31(12):77-9, 83-4. PubMed ID: 8969681 [No Abstract] [Full Text] [Related]
10. After managed care, what? Shore MF Harv Rev Psychiatry; 2000; 7(6):365-70. PubMed ID: 10749394 [No Abstract] [Full Text] [Related]
11. Managed health care: outcomes and update. Wenzel RP Curr Clin Top Infect Dis; 1999; 19():216-25. PubMed ID: 10472488 [No Abstract] [Full Text] [Related]
12. Cost-effectiveness analysis: from science to application. Berger ML; Teutsch S Med Care; 2005 Jul; 43(7 Suppl):49-53. PubMed ID: 16056009 [TBL] [Abstract][Full Text] [Related]
13. Pharmacoeconomics comes of age? Walley T; Breckenridge A Clin Pharmacol Ther; 2008 Aug; 84(2):279-80. PubMed ID: 18563057 [TBL] [Abstract][Full Text] [Related]
14. Pharmacoeconomic series: Part I. Pharmacoeconomics and the evaluation of drugs and services. McGhan WF Hosp Formul; 1993 Apr; 28(4):365-6, 371-3, 377-8. PubMed ID: 10125323 [TBL] [Abstract][Full Text] [Related]
15. Use of randomized controlled trials in organizational decision making: a cost-minimization approach. Cher DJ; Maclure M Am J Manag Care; 2000 Aug; 6(8):894-904. PubMed ID: 11186501 [No Abstract] [Full Text] [Related]
16. Providing cost-effective therapy using pharmacoeconomic evaluations: the public sector approach. Finder S Clin Ther; 1997; 19(1):160-6. PubMed ID: 9182021 [TBL] [Abstract][Full Text] [Related]
17. Managing health care quality can lower costs and generate access. O'Brien GR Benefits Q; 1991; 7(4):17-22. PubMed ID: 10116953 [No Abstract] [Full Text] [Related]
18. Marketplace. Assessing medical innovations: how health plans pick what technology to cover. Moskowitz DB Faulkner Grays Med Health; 1997 May; 51(21):suppl 2 p.. PubMed ID: 10167124 [No Abstract] [Full Text] [Related]
19. A primer on dynamic optimization and optimal control in pharmacoeconomics. Vernon JA; Hughen WK Value Health; 2006; 9(2):106-13. PubMed ID: 16626414 [TBL] [Abstract][Full Text] [Related]
20. Cost of treating mental illness from a managed care perspective. Docherty JP J Clin Psychiatry; 1999; 60 Suppl 3():49-52; discussion 53. PubMed ID: 10073378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]